Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Invitrogen

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 17 December 1993:
Vol. 262. no. 5141, p. 1803
DOI: 10.1126/science.262.5141.1803-a
Prev | Table of Contents | Next

Articles

Corrections and Clarifications

The ScienceScope item "NIH shakeup continues" (29 Oct., p. 643) incorrectly described the position of Francis Collins, director of the National Center for Human Genome Research, on the National Institutes of Health's (NIH's) decision 2 years ago to file for patents on gene fragments of unknown function. Collins does not believe it was appropriate for NIH to file for the patents in the first place, but since the applications have been filed, he now believes they should be pursued to a conclusion in order to clarify whether such gene fragments are patentable.

ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)